ATX101 Provided Sustained Pain Relief in TKA Patients: Results of an Exploratory Multicenter Double-Blind RCT
November 7, 2024
Presentations and Publications
In The News
SINGAPORE’S NEXT CHALLENGE: TURNING MOMENTUM INTO SUSTAINABLE GROWTH
BioCentury | January 29, 2024ALLAY THERAPEUTICS: A SITE-SPECIFIC DRUG IMPLANT TREATS POSTSURGICAL PAIN
MedTech Strategist | February 13, 2023Peninsula startup is seeking $60M for its opioid-free crackdown on pain
San Francisco Business Times | May 13, 2021